John R. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 401,250 shares at $17.00 ($6.8M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
Open-market sale of $6.8M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |